0001213900-23-089578.txt : 20231122 0001213900-23-089578.hdr.sgml : 20231122 20231122160516 ACCESSION NUMBER: 0001213900-23-089578 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231122 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akso Health Group CENTRAL INDEX KEY: 0001702318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38245 FILM NUMBER: 231433399 BUSINESS ADDRESS: STREET 1: RM 8201-4-4(A) 2ND FLOOR QIANTONGYUA BLD STREET 2: NO. 44 MOSCOW RD QIANWAN BONDED PORT ARE CITY: QINGDAO PILOT FREE TRADE ZONE STATE: F4 ZIP: 0000 BUSINESS PHONE: 86 152 1005 4919 MAIL ADDRESS: STREET 1: RM 8201-4-4(A) 2ND FLOOR QIANTONGYUA BLD STREET 2: NO. 44 MOSCOW RD QIANWAN BONDED PORT ARE CITY: QINGDAO PILOT FREE TRADE ZONE STATE: F4 ZIP: 0000 FORMER COMPANY: FORMER CONFORMED NAME: Xiaobai Maimai Inc. DATE OF NAME CHANGE: 20201221 FORMER COMPANY: FORMER CONFORMED NAME: Hexindai Inc. DATE OF NAME CHANGE: 20170328 6-K 1 ea188928-6k_aksohealth.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2023

 

Commission File Number: 001-38245

 

Akso Health Group

(Exact name of registrant as specified in its charter)

 

Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building,

No. 44, Moscow Road, Qianwan Bonded Port Area,

Qingdao Pilot Free Trade Zone, China (Shandong)

Tel: +86 152 1005 4919

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒            Form 40-F ☐

 

 

 

 

 

 

Closing of Private Placement

 

As disclosed on Akso Health Group’s (the “Company”) Report on Form 6-K filed with the Securities and Exchange Commission on November 17, 2023, the Company entered into certain securities purchase agreement (the “SPA”) on November 16, 2023 with certain “non-U.S. Persons” (the “Purchasers”) as defined in Regulation S of the Securities Act of 1933, as amended, pursuant to which the Company agreed to sell an aggregate of 53,608,910 units (the “Units”), each Unit consisting of one Ordinary Share of the Company, par value $0.0001 per share (“Share”) and a warrant to purchase one Share (“Warrant”) with an initial exercise price of $0.52875, or approximately $1.59 per American depositary share of the Company (“ADS”), at a price of $0.423 per Unit, or approximately $1.27 per ADS for an aggregate purchase price of approximately $22.68 million (the “Offering”), subject to various conditions to closing.

 

On November 21, 2023, the transaction contemplated by the SPA consummated when all the closing conditions of the SPA have been satisfied and the Company issued the Units to the Purchasers pursuant to the SPA.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Akso Health Group
   
  By: /s/ Yilin (Linda) Wang
  Name:  Yilin (Linda) Wang
  Title: Chief Executive Officer
   
Date: November 22, 2023  

 

 

2